Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-30 Purchase |
2021-04-01 6:16 pm |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
25,000 | $20 | $500,000 | 154,923 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 7:00 pm |
N/A 2035-01-01 |
Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson |
600,000 | $0 | 600,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-13 Gift |
2024-06-17 6:39 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director |
1,332,900 | $0 | 4,824,554 (Indirect) |
View |
| 2024-06-07 Gift |
2024-06-07 9:11 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director 10% Owner |
1,332,950 | $0 | 6,157,454 (Indirect) |
View |
| 2024-06-04 Other(A) |
2024-06-07 9:09 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner |
2,665,800 | $0 | 10,156,204 (Indirect) |
View |
| 2024-06-04 Gift |
2024-06-06 4:32 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner |
1,332,900 | $0 | 3,998,700 (Indirect) |
View |
| 2024-06-04 Other |
2024-06-06 4:32 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner |
2,665,800 | $0 | 3,998,700 (Indirect) |
View |
| 2023-09-01 Option Award |
2023-09-05 5:33 pm |
N/A 2033-08-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson |
2,100,000 | $0 | 2,100,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-28 9:00 pm |
N/A 2033-06-26 |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director 10% Owner |
40,000 | $0 | 40,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:40 pm |
N/A 2033-01-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
415,000 | $0 | 415,000 (Direct) |
View |
| 2022-11-08 Option Award |
2022-11-10 6:00 pm |
N/A 2031-11-30 |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner |
10,510,774 | $0 | 10,510,774 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:50 pm |
N/A 2032-01-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
475,000 | $0 | 475,000 (Direct) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:16 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
275,948 | $0 | 154,923 (Indirect) |
View |
Ownership |
2021-03-25 9:09 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
0 | $0 | 104,923 (Indirect) |
View |